| Product Code: ETC6902948 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
In 2024, Cyprus continued to rely heavily on imports of pregabalin, with key exporters being India, China, Germany, Netherlands, and the USA. The market concentration, as measured by the HHI, remained very high, indicating limited competition. Despite a negative CAGR of -4.6% from 2020-2024, there was a slight improvement in the growth rate in 2024 at -1.98%. This data suggests a challenging market environment for pregabalin imports in Cyprus, with potential implications for pricing and supply dynamics.

| 1 Executive Summary | 
| 2 Introduction | 
| 2.1 Key Highlights of the Report | 
| 2.2 Report Description | 
| 2.3 Market Scope & Segmentation | 
| 2.4 Research Methodology | 
| 2.5 Assumptions | 
| 3 Cyprus Pregabalin Market Overview | 
| 3.1 Cyprus Country Macro Economic Indicators | 
| 3.2 Cyprus Pregabalin Market Revenues & Volume, 2021 & 2031F | 
| 3.3 Cyprus Pregabalin Market - Industry Life Cycle | 
| 3.4 Cyprus Pregabalin Market - Porter's Five Forces | 
| 3.5 Cyprus Pregabalin Market Revenues & Volume Share, By Application, 2021 & 2031F | 
| 3.6 Cyprus Pregabalin Market Revenues & Volume Share, By Drug Class, 2021 & 2031F | 
| 3.7 Cyprus Pregabalin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F | 
| 4 Cyprus Pregabalin Market Dynamics | 
| 4.1 Impact Analysis | 
| 4.2 Market Drivers | 
| 4.3 Market Restraints | 
| 5 Cyprus Pregabalin Market Trends | 
| 6 Cyprus Pregabalin Market, By Types | 
| 6.1 Cyprus Pregabalin Market, By Application | 
| 6.1.1 Overview and Analysis | 
| 6.1.2 Cyprus Pregabalin Market Revenues & Volume, By Application, 2021- 2031F | 
| 6.1.3 Cyprus Pregabalin Market Revenues & Volume, By Epilepsy, 2021- 2031F | 
| 6.1.4 Cyprus Pregabalin Market Revenues & Volume, By Neuropathic Pain, 2021- 2031F | 
| 6.1.5 Cyprus Pregabalin Market Revenues & Volume, By Anxiety Disorder, 2021- 2031F | 
| 6.1.6 Cyprus Pregabalin Market Revenues & Volume, By Others, 2021- 2031F | 
| 6.2 Cyprus Pregabalin Market, By Drug Class | 
| 6.2.1 Overview and Analysis | 
| 6.2.2 Cyprus Pregabalin Market Revenues & Volume, By Fibromyalgia Agents, 2021- 2031F | 
| 6.2.3 Cyprus Pregabalin Market Revenues & Volume, By Anticonvulsants, 2021- 2031F | 
| 6.2.4 Cyprus Pregabalin Market Revenues & Volume, By Others, 2021- 2031F | 
| 6.3 Cyprus Pregabalin Market, By Distribution Channel | 
| 6.3.1 Overview and Analysis | 
| 6.3.2 Cyprus Pregabalin Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F | 
| 6.3.3 Cyprus Pregabalin Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F | 
| 6.3.4 Cyprus Pregabalin Market Revenues & Volume, By Online Pharmacy, 2021- 2031F | 
| 6.3.5 Cyprus Pregabalin Market Revenues & Volume, By Others, 2021- 2031F | 
| 7 Cyprus Pregabalin Market Import-Export Trade Statistics | 
| 7.1 Cyprus Pregabalin Market Export to Major Countries | 
| 7.2 Cyprus Pregabalin Market Imports from Major Countries | 
| 8 Cyprus Pregabalin Market Key Performance Indicators | 
| 9 Cyprus Pregabalin Market - Opportunity Assessment | 
| 9.1 Cyprus Pregabalin Market Opportunity Assessment, By Application, 2021 & 2031F | 
| 9.2 Cyprus Pregabalin Market Opportunity Assessment, By Drug Class, 2021 & 2031F | 
| 9.3 Cyprus Pregabalin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F | 
| 10 Cyprus Pregabalin Market - Competitive Landscape | 
| 10.1 Cyprus Pregabalin Market Revenue Share, By Companies, 2024 | 
| 10.2 Cyprus Pregabalin Market Competitive Benchmarking, By Operating and Technical Parameters | 
| 11 Company Profiles | 
| 12 Recommendations | 
| 13 Disclaimer |